focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I don't think they got in through the back door, Peter O'Toole has been involved with Bolivia for 30 years and, in 2018 the Bolivian authorities invited Clontarf back to discussions with YLB so I'd say they've virtually got the keys to the main entrance. GLA and DYOR
LS, you could well be right there. Also, it appears that "For GM, a key priority is to unlock a North American supply of lithium" and "The auto giant believes that EnergyX’s technology could reduce costs enough to make North American lithium mining viable". So it appears that GM are looking for a more cost-effective method of mining lithium in their backyard. GLA and DYOR
Lostsoul, if you read the EnergyX roadmap, they signed a "Pilot Technology Agreement at Largest Lithium Reserve in the world" with YLB in October 2021. However, that was 18 months ago now so it's unclear to me why there appears to have been no rollout to production announced, and yet GM are now investing $50M in EnergyX to set up more pilot plants. I shall try to do a bit more digging if you'll excuse the pun but could do with more news from Clontarf. GLA and DYOR
London, yes I looked into Cornish Lithium back in February whilst researching this prospect. It appears there are many players developing DLE technologies, and many lithium extraction companies licencing proprietary solutions including Next-ChemX and EnergyX. From what I've read there is no one size fits all solution since it depends on the composition of the extracted brines. There are lots of opportunities in this race. DYOR and GLA
Burnemc, as Lostsoul says, the information is there if only people were prepared to look for it. This is a great opportunity but it is still early days. I think Clontarf are biding their time whilst getting all ducks lined up. Be patient and all being well our patience will be rewarded. GLA
Lending, answers my post on 27th February...
"having developed a product and deployed it then wouldn't the AI component then be effectively "developing" itself by learning and adapting ?" GLA
I will repeat my post from earlier today in case it got overlooked by all the ramping posts...
11:56 I'm a modest investor in Clontarf and continuing to hold because I like the look of their environmentally friendly lithium extraction solution and their long history of working with the Bolivian government. However, it appears the locals remain resistant and seeking improved benefits for local communities...
https://www.reuters.com/world/americas/bolivias-heartland-protests-rattle-lithium-development-push-2023-03-16/
There is also the small matter of the Bolivian government and YLB having already signed an agreement with a Chinese consortium including CATL. However, my understanding is that this is a different location to Clontarf's site, is this correct ?
https://thediplomat.com/2023/02/in-bolivia-china-signs-deal-for-worlds-largest-lithium-reserves/
I'm not looking to spread fear or doom and gloom, just sharing my thoughts and interested to know fellow investors views.
GLA and DYOR
I'm a modest investor in Clontarf and continuing to hold because I like the look of their environmentally friendly lithium extraction solution and their long history of working with the Bolivian government. However, it appears the locals remain resistant and seeking improved benefits for local communities...
https://www.reuters.com/world/americas/bolivias-heartland-protests-rattle-lithium-development-push-2023-03-16/
There is also the small matter of the Bolivian government and YLB having already signed an agreement with a Chinese consortium including CATL. However, my understanding is that this is a different location to Clontarf's site, is this correct ?
https://thediplomat.com/2023/02/in-bolivia-china-signs-deal-for-worlds-largest-lithium-reserves/
I'm not looking to spread fear or doom and gloom, just sharing my thoughts and interested to know fellow investors views.
GLA and DYOR
Came across this article about therapeutic antibodies and patents. The gist of it appears to be questioning the validity of generic vs specific patents, the implications it might have on the development of new drugs, and more importantly the impact on companies investing in R&D if returns are reduced...
https://www.nature.com/articles/d41586-023-00911-7
Plunger2, I might be oversimplifying things but wouldn't be surprised if they haven't got a standard template document and just fill in the blanks as necessary. It's then going to go to DT BoDs for review before it's approved and issued. Nonetheless if they issue it too quickly then it might be questioned how thorough a job has been done and too long then what problems have E&Y found. Either way they're potentially on a hiding to nothing. gla